Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laszlo Vecsei

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Medicinal Chemistry (Shariqah (United Arab Emirates))|May 17, 2007
Peripheral kynurenine metabolism in focal dystoniaZsuzsanna Hartai, Peter Klivenyi, Tamas Janaky, et al.
European Journal of Pharmacology|September 12, 2009
Modulatory effects of probenecid on the nitroglycerin-induced changes in the rat caudal trigeminal nucleusEniko Vamos, Arpad Pardutz, Annamaria Fejes, et al.
Journal of the Neurological Sciences|August 16, 2005
Kynurenine metabolism in plasma and in red blood cells in Parkinson's diseaseZsuzsanna Hartai, Peter Klivenyi, Tamas Janaky, et al.
Journal of the Neurological Sciences|May 28, 2013
Evaluating biomarkers of neuronal degeneration and neuroinflammation in CSF of patients with multiple sclerosis-osteopontin as a potential marker of clinical severityLevente Szalardy, Denes Zadori, Mihaela Simu, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|March 21, 2020
Predictors of localization, outcome, and etiology of spontaneous intracerebral hemorrhages: focus on cerebral amyloid angiopathyBernadett Fakan, Zita Reisz, Denes Zadori, et al.
Current Medicinal Chemistry|July 15, 2017
Migraine, Neurogenic Inflammation, Drug Development - Pharmacochemical AspectsMelinda Lukacs, Janos Tajti, Ferenc Fulop, et al.
Current Topics in Medicinal Chemistry|October 4, 2012
Manipulating kynurenic acid levels in the brain - on the edge between neuroprotection and cognitive dysfunctionLevente Szalardy, Denes Zadori, Jozsef Toldi, et al.
Neuroscience Letters|September 12, 2013
Elevated levels of PPAR-gamma in the cerebrospinal fluid of patients with multiple sclerosisLevente Szalardy, Denes Zadori, Ervin Tanczos, et al.
Behavioural Brain Research|January 31, 2006
Behaviour changes in a transgenic model of Huntington's diseasePeter Klivenyi, Zsuzsanna Bende, Zsuzsanna Hartai, et al.
Brain Research Bulletin|June 7, 2008
The pentylenetetrazole-induced activity in the hippocampus can be inhibited by the conversion of L-kynurenine to kynurenic acid: an in vitro studyEva Rozsa, Hermina Robotka, David Nagy, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Medicinal Chemistry (Shariqah (United Arab Emirates))|May 17, 2007
Peripheral kynurenine metabolism in focal dystoniaZsuzsanna Hartai, Peter Klivenyi, Tamas Janaky, et al.
European Journal of Pharmacology|September 12, 2009
Modulatory effects of probenecid on the nitroglycerin-induced changes in the rat caudal trigeminal nucleusEniko Vamos, Arpad Pardutz, Annamaria Fejes, et al.
Journal of the Neurological Sciences|August 16, 2005
Kynurenine metabolism in plasma and in red blood cells in Parkinson's diseaseZsuzsanna Hartai, Peter Klivenyi, Tamas Janaky, et al.
Journal of the Neurological Sciences|May 28, 2013
Evaluating biomarkers of neuronal degeneration and neuroinflammation in CSF of patients with multiple sclerosis-osteopontin as a potential marker of clinical severityLevente Szalardy, Denes Zadori, Mihaela Simu, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|March 21, 2020
Predictors of localization, outcome, and etiology of spontaneous intracerebral hemorrhages: focus on cerebral amyloid angiopathyBernadett Fakan, Zita Reisz, Denes Zadori, et al.
Current Medicinal Chemistry|July 15, 2017
Migraine, Neurogenic Inflammation, Drug Development - Pharmacochemical AspectsMelinda Lukacs, Janos Tajti, Ferenc Fulop, et al.
Current Topics in Medicinal Chemistry|October 4, 2012
Manipulating kynurenic acid levels in the brain - on the edge between neuroprotection and cognitive dysfunctionLevente Szalardy, Denes Zadori, Jozsef Toldi, et al.
Neuroscience Letters|September 12, 2013
Elevated levels of PPAR-gamma in the cerebrospinal fluid of patients with multiple sclerosisLevente Szalardy, Denes Zadori, Ervin Tanczos, et al.
Behavioural Brain Research|January 31, 2006
Behaviour changes in a transgenic model of Huntington's diseasePeter Klivenyi, Zsuzsanna Bende, Zsuzsanna Hartai, et al.
Brain Research Bulletin|June 7, 2008
The pentylenetetrazole-induced activity in the hippocampus can be inhibited by the conversion of L-kynurenine to kynurenic acid: an in vitro studyEva Rozsa, Hermina Robotka, David Nagy, et al.
Pageof 7